ClinicalTrials.Veeva

Menu

Extended Depth of Focus Contact Lenses for Presbyopia

V

Visioneering Technologies

Status

Completed

Conditions

Presbyopia

Treatments

Device: NaturalVue Multifocal

Study type

Interventional

Funder types

Industry

Identifiers

NCT05495971
VTI-2206

Details and patient eligibility

About

VTI has an FDA cleared soft contact lens product. Its optical design creates an enhanced depth of focus (EDOF), which provides clear distance, intermediate, and near vision. This study is to quantify the enhanced depth of focus and visual impact.

Full description

This study will develop defocus curves for Baseline best corrected spectacle refraction and then for the EDOF lens used in this study. A comparison of thge depth of focus for each condition will be made.

Enrollment

24 patients

Sex

All

Ages

45 to 70 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Suitable and able to wear contact lenses
  • Normal best corrected vision (20/25 or better)
  • Need reading add +2.00 or stronger

Exclusion criteria

  • Pre-existing ocular condition that would contraindicating lens wear

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

24 participants in 1 patient group

Presbyopia
Experimental group
Description:
Subject's baseline vision will be compared with vision wearing treatment product
Treatment:
Device: NaturalVue Multifocal

Trial documents
1

Trial contacts and locations

1

Loading...

Central trial contact

Doug Benoit, OD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems